Your Roommate Has Chlamydia (and Other STD Shocks from Campus Life)

Published: April 2025 | Last updated: May 2026

The Centers for Disease Control and Prevention attributes roughly half of all new sexually transmitted infections in the United States each year to people aged 15 to 24 (per CDC surveillance data through 2022), even though that age group is only about a quarter of the sexually active population. College campuses concentrate exactly that demographic, often in close quarters, often with new partners. The math is not subtle. (Note: STI and STD are used interchangeably here; public-health bodies now prefer "infection" over "disease" because most cases are asymptomatic.)

What follows is not a panic piece. It is what current public-health data actually says about how common STIs are in this age range, why so many infections stay undetected, when testing makes sense and when it does not, and what at-home rapid tests can and cannot answer. The goal is enough specific information to make an informed decision without having to read another scary headline.

How Common Are STIs on College Campuses?

The numbers vary by source and by infection, but a few baseline figures hold up across CDC surveillance and major college-health surveys.

The CDC's most recent finalized STI surveillance cycles attribute roughly half of new sexually transmitted infections in the United States to people aged 15 to 24. Chlamydia is the most reported bacterial STI in this age range, with the highest rates in women aged 20 to 24. Gonorrhea rates in young adults have climbed steadily over the past decade. Syphilis, once uncommon in this demographic, has been rising sharply, with the steepest increases among men who have sex with men and in some racial and ethnic communities.

HPV is the most common STI overall. The CDC estimates that nearly all sexually active people will acquire at least one HPV type at some point, often within the first few years of becoming sexually active. Most of these infections clear on their own, but certain high-risk strains can cause cervical, anal, oropharyngeal, or penile cancers years later.

Herpes simplex virus is harder to pin down because most diagnoses happen through symptom recognition rather than routine screening. CDC seroprevalence surveys suggest roughly one in eight Americans aged 14 to 49 carries HSV-2 infection, and most do not know it. HSV-1, traditionally the cold-sore virus, is increasingly responsible for genital herpes acquired through oral sex.

These figures describe a national baseline. Specific campuses vary widely depending on local epidemiology, student demographics, and access to sexual-health services. State surveillance dashboards (most state health departments publish them) are the better source for local rates. (Disclosure: stdrapidtestkits.com sells the rapid at-home kits referenced below; we recommend products based on fit for the reader's concern, not commercial benefit.)

7-in-1 Rapid At-Home STI Panel

7-in-1 STD At-Home Rapid Test Kit

$413.00

A combined panel covering seven of the most common sexually transmitted infections, drawing on fingerstick blood and self-collected genital swab samples. Lateral-flow rapid results in about 15 minutes per test. Discreet screening you can run from your dorm or apartment, with no clinic appointment to schedule.

See the 7-in-1 Kit

Why Campus Life Elevates Risk

Three factors converge in the typical undergraduate experience, and they are mostly structural rather than behavioral.

The first is partner concurrency. Compared with older adults, college students are more likely to have multiple sexual partners within overlapping time windows. Sexual networks shaped this way transmit infections faster than serial monogamy because someone newly infected can spread to several partners before any symptoms (if there ever are any) appear.

The second is inconsistent barrier use. The American College Health Association National College Health Assessment, which has surveyed hundreds of thousands of students, consistently finds that fewer than half of sexually active students report condom use during their most recent vaginal sex. Use rates drop further for oral and anal sex, where many students perceive the risk as minimal.

The third is alcohol. The same ACHA data shows that students who report drinking before sex are less likely to use condoms and more likely to have had regretted decisions, including unprotected encounters with new partners.

None of this means students should panic about every hookup. It means the population-level math favors regular testing for anyone sexually active with new or multiple partners, regardless of how careful any single encounter felt.

Most College STIs Are Silent

The single most important fact about chlamydia, gonorrhea, and HPV in this age group is that the majority of infections cause no symptoms at all. Published CDC asymptomatic prevalence estimates from surveillance data suggest that roughly 70 percent of women and at least 50 percent of men with chlamydia have no noticeable signs; the CDC chlamydia fact sheet describes the infection as one that "often has no symptoms." Gonorrhea is similarly quiet in most women and many men. HPV almost never causes symptoms unless visible warts develop, and even cancer-precursor changes in cervical cells are invisible without screening.

Silent infection is what drives transmission. Someone who feels fine continues to have sex, often without thinking testing is relevant. The infection then spreads to new partners, who also feel fine, and the chain continues. By the time the original infection produces a complication (pelvic inflammatory disease, epididymitis, an abnormal Pap result, or reactive arthritis), several other people may already be infected.

The long-term consequences land disproportionately on women. Untreated chlamydia and gonorrhea are leading causes of tubal-factor infertility, ectopic pregnancy, and chronic pelvic pain. These outcomes are largely preventable through routine screening and prompt treatment, both of which require knowing the infection is there.

This is why the CDC STI Treatment Guidelines recommend routine annual chlamydia and gonorrhea screening for all sexually active women under 25, and for sexually active men in higher-risk groups. It is the only practical way to catch what would otherwise stay invisible.

Oral Sex Transmits More Than People Think

The widespread assumption that oral sex carries minimal STI risk does not match the clinical picture. Gonorrhea, chlamydia, syphilis, herpes, and HPV can all infect the pharynx through oral contact. Pharyngeal gonorrhea has been rising in young adults and is frequently asymptomatic, which is part of what makes it a quiet contributor to broader population spread.

At-home lateral-flow swab kits for chlamydia and gonorrhea, including the panels sold on this site, are validated for self-collected genital sample collection, not pharyngeal or rectal swabs. If you specifically need a throat test after oral exposure to a partner with known or suspected gonorrhea, a clinic visit for a pharyngeal nucleic acid amplification test (NAAT) swab is the right test. The at-home panel can rule out the genital or systemic infections that often accompany oral exposure (since people who give oral sex frequently also have genital sex with the same partner), but it does not diagnose a throat-only infection.

Herpes is a separate case. Antibody testing through a blood sample, such as the HSV-1 or HSV-2 single-test kits or the combined herpes panel, detects past infection but cannot specify the anatomic location of an outbreak. For an active visible lesion, a clinic-administered swab tested by PCR is the most accurate diagnostic, regardless of body site.

When to Test: Window Periods That Actually Matter

Testing too soon after an exposure produces false-negative results because the body has not yet generated detectable infection markers. The relevant windows differ by infection and by test technology.

The table below summarizes typical earliest-reliable-test dates for the infections covered in standard at-home and clinic-based STI panels. These ranges are drawn from CDC testing guidance and assay manufacturer documentation. A test taken before the lower bound is likely too early to detect a recent infection. A test taken after the upper bound, with no new exposures in between, gives a reliable negative for that specific exposure event.

For sexually active students with new partners, the practical screening cadence is every 3 to 6 months for the routine bacterial panel (chlamydia, gonorrhea), with annual HIV and syphilis screening at minimum. More frequent testing after a high-risk exposure (unprotected sex with someone whose status is unknown) is appropriate. A one-time check on hepatitis B immunity is worth doing if vaccination records are unclear, since most students vaccinated in childhood still have protective antibody titers.

Reading the table: "Earliest reliable test" is measured from the date of the exposure event. The "Conservative retest" column applies after a confirmed positive (to detect reinfection from an untreated partner) or as a second-look check at the upper bound of the window when a first-pass negative result was taken early. The 4th-generation antigen/antibody HIV test detects both the HIV p24 antigen and HIV antibodies, which is why it picks up infection earlier than antibody-only rapid tests. The lab version's tighter 45-day outer bound reflects that higher analytical sensitivity; the rapid antibody-only home test can take up to 90 days to turn positive.

HPV Vaccination Still Helps in Your Twenties

The HPV vaccine (Gardasil 9 in the United States) is most effective when given before any sexual activity, which is why the CDC Advisory Committee on Immunization Practices (ACIP) recommends routine vaccination starting at age 11 or 12. ACIP recommends routine catch-up vaccination through age 26 for anyone who was not adequately vaccinated earlier. For adults aged 27 through 45, ACIP recommends shared clinical decision-making, meaning a conversation with a provider about whether vaccination still offers meaningful benefit based on likely past exposure and future risk.

For most college students, the practical reading is: if you were not fully vaccinated as a preteen or teenager, getting vaccinated now still protects against the HPV types you have not yet encountered. The vaccine covers nine HPV strains responsible for the majority of HPV-attributable cancers and most genital warts.

HPV vaccination is covered without cost-sharing by most insurance plans, including most student health plans, under federal preventive-service rules. Campus health centers typically administer it, and many community pharmacies do as well. The series is two or three doses depending on the age at first dose.

Condoms Work, but Not Against Everything

Correctly and consistently used external (male) condoms are effective at preventing transmission of fluid-borne infections: HIV, chlamydia, gonorrhea, hepatitis B, and trichomoniasis. They also reduce, but do not eliminate, the risk of skin-to-skin infections like herpes, HPV, and syphilis chancres, because those can transmit from areas the condom does not cover.

Internal (female) condoms offer comparable protection and are useful when the partner with the penis declines to use an external condom. Dental dams (latex sheets used during oral sex on a vulva or anus) reduce oral-to-genital and oral-to-anal STI transmission risk, though their real-world use rate remains very low.

Pre-exposure prophylaxis (PrEP) for HIV is the other major prevention tool. Daily oral PrEP reduces HIV acquisition risk by more than 99 percent when taken consistently. Long-acting injectable cabotegravir is now an FDA-approved alternative for those who prefer not to take a daily pill. PrEP does not protect against other STIs, so it is typically combined with regular STI screening every 3 months.

For exposure that has already happened, post-exposure prophylaxis (PEP) is a 28-day course of HIV antiretrovirals started within 72 hours that substantially reduces the risk of HIV acquisition. PEP is available through emergency departments, urgent-care clinics, and many campus health centers.

Six Common STI Myths Worth Dropping

"I would know if I had one." Most chlamydia, gonorrhea, and HPV infections cause no symptoms. HIV often produces only mild flu-like symptoms during early infection that pass unnoticed. Symptom-based self-diagnosis misses the majority of cases.

"Only people who sleep around get STIs." One partner is enough if that partner has an undiagnosed infection. Population risk scales much more with the partner's history than with personal partner count.

"Oral does not count." Gonorrhea, chlamydia, syphilis, herpes, and HPV all transmit through oral contact. Pharyngeal infections are usually silent and contribute to ongoing transmission chains.

"We are exclusive, so testing is not needed." A monogamous relationship protects against new outside transmission, but pre-existing undiagnosed infections from either partner's prior sexual history can still be present. A baseline test before stopping condom use is reasonable.

"Only certain populations get HIV." HIV does have higher incidence rates in some communities, including men who have sex with men and certain racial and ethnic groups, but the virus does not discriminate biologically. Anyone with HIV exposure can acquire HIV.

"You can catch STIs from toilet seats." No. STI pathogens require direct skin-to-skin or mucous-membrane contact with infected fluids or lesions. Toilet seats, towels, swimming pools, and shared utensils do not transmit STIs.

Young people are at greater risk of getting an STI for several reasons, including not getting the recommended STI tests, having multiple sex partners, and biological factors. Half of new infections occur in people aged 15 to 24.

Where to Test: Campus Clinic vs At-Home

The trade-offs between testing options come down to sample type, turnaround, cost, and privacy.

Campus health centers and Title X-funded clinics (such as Planned Parenthood) typically offer the most comprehensive testing, including pharyngeal and rectal swabs for gonorrhea and chlamydia where clinically indicated. Lab-processed NAATs are the analytical gold standard because their sensitivity for low-level infections is higher than lateral-flow rapid tests. Many campus clinics offer free or sliding-scale testing for enrolled students. The privacy caveat is that insurance billing can generate an Explanation of Benefits sent to the policyholder, which is a real concern for students still on a parent's plan. Most colleges can route billing to avoid this, but it requires asking.

At-home rapid lateral-flow kits, including the panels sold here, are screening tools. They use the same swab and blood-sample types as clinic tests but with lateral-flow chemistry rather than NAAT or laboratory immunoassay. They are useful for routine screening, for people who want privacy from campus health-center staff, and for quick checks between scheduled clinic visits. A positive at-home result should be confirmed with a clinic-based NAAT or laboratory antibody test before treatment, since lateral-flow specificity is high but not perfect. A negative result, taken after the relevant window period, is reliable for that exposure event.

For students who anticipate testing every few months, an at-home kit reduces friction: the test happens when the question comes up, not after a two-week wait for an appointment.

2-in-1 Chlamydia and Gonorrhea Swab

Chlamydia & Gonorrhea 2-in-1 At-Home Rapid Test Kit

$118.00

The two most common bacterial STIs on college campuses, tested together with one self-collected genital swab. Rapid lateral-flow result in about 15 minutes. A fit-for-purpose option for the every-few-months screening cadence that CDC guidance recommends for sexually active people under 25.

See the 2-in-1 Swab Kit

1. U.S. Centers for Disease Control and Prevention. Sexually Transmitted Infections Surveillance, annual reports including age-specific incidence figures for the 15 to 24 demographic and trend data on chlamydia, gonorrhea, and syphilis.
2. U.S. Centers for Disease Control and Prevention. Chlamydia fact sheet covering asymptomatic infection, screening recommendations for sexually active women under 25, and complications including pelvic inflammatory disease.
3. U.S. Centers for Disease Control and Prevention. HPV vaccination recommendations from the Advisory Committee on Immunization Practices, including routine vaccination age, catch-up vaccination through age 26, and shared clinical decision-making for ages 27 to 45.
4. American College Health Association. National College Health Assessment (NCHA), the largest ongoing survey of U.S. college student health behaviors including condom use rates, partner counts, and alcohol-associated sexual behavior.
5. U.S. Centers for Disease Control and Prevention. HIV testing guidance, including window periods for fourth-generation antigen/antibody assays (18 to 45 days), rapid antibody tests (23 to 90 days), and nucleic-acid testing.
6. U.S. Centers for Disease Control and Prevention. STI Treatment Guidelines, including screening recommendations for sexually active women under 25 and extragenital site screening guidance for gonorrhea and chlamydia.

Sam Harper

Sam covers at-home sexual-health testing, public-health guidance, and clinical-testing basics for general audiences. Has been writing about consumer health since 2019, with a focus on translating CDC and WHO guidance into plain-English action items. Not a clinician; articles are summaries, not advice.